Over the decades, scientists have revealed many strategies that keep normal cells from becoming cancerous. Understanding natural anti-tumor processes could help researchers develop better approaches ...
(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder cancer and only modestly extended the lives of previously treated patients with late-stage lung ...
Explore new findings on bladder cancer and inflammation's role in immune suppression. Discover insights to improve treatment.
NCCN now includes Anktiva plus BCG for BCG-unresponsive papillary-only NMIBC, acknowledging an unmet need in patients without CIS who have limited post-BCG options. Radical cystectomy remains ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The drug is approved for breast ...
For years, Susan Johnstone, 53, lived with an embarrassing problem that threatened to take away the activity she loved most: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results